Molecular mechanisms that lead to reduced expression of Duffy antigens

Transfusion

Volumn 40, Issue 3, 2000, Pages 310-320

  Yazdanbakhsh, Karina ^a   Rios, M ^b   Storry, J R ^b   Kosower, N ^b   Parasol, N ^b   Chaudhuri, A ^b   Reid, M E ^b  

^a NEW YORK BLOOD CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; INTERLEUKIN 8;

ANTIGEN EXPRESSION; ARTICLE; BLOOD DONOR; BLOOD GROUP DUFFY SYSTEM; CONTROLLED STUDY; FLOW CYTOMETRY; GENE FREQUENCY; GENE MUTATION; GENETIC TRANSFECTION; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS;

AFRICAN CONTINENTAL ANCESTRY GROUP; BLOTTING, NORTHERN; BLOTTING, WESTERN; CHEMOKINES; DUFFY BLOOD-GROUP SYSTEM; EUROPEAN CONTINENTAL ANCESTRY GROUP; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; ISOANTIGENS; MUTAGENESIS, SITE-DIRECTED; NEW YORK; PHENOTYPE; POINT MUTATION; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; TRANSFECTION; VARIATION (GENETICS);

EID: 0034026638     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40030310.x     Document Type: Article

References (48)

1. Cutbush M, Mollison PI, Parkin DM. A new human blood group. Nature 1950;165:188.
2. Cutbush M, Mollison PL. The Duffy blood group system. Heredity 1950;4:383-9.
3. Chaudhuri A, Polyakova J, Zbrzezna V, Pogo AO. The coding sequence of Duffy blood group gene in humans and simians: restriction fragment length polymorphism, antibody and malarial parasite specificities, and expression in nonerythroid tissues in Duffy-negative individuals. Blood 1995;85:615-21.
4. b alloantigen system is associated with a polymorphism at the 44-amino acid residue. Blood 1995;85:622-6.
5. b antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype. Br J Haematol 1995;90:823-9.
6. b blood group polymorphism. Hum Genet 1995;95:407-10.
7. Donahue RP, Bias WB, Renwick JH, McKusick VA. Probable assignment of the Duffy blood group locus to chromosome 1 in man. Proc Natl Acad Sci U S A 1968;61:949-55.
8. Lu ZH, Wang ZX, Horuk R, et al. The promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines is primarily localized to sequences in the amino-terminal domain. J Biol Chem 1995;270:26239-45.
9. Wasniowska K, Blanchard D, Janvier D, et al. Identification of the Fy6 epitope recognized by two monoclonal antibodies in the N-terminal extracellular portion of the Duffy antigen receptor for chemokines. Mol Immunol 1996;33:917-23.
10. Tournamille C, Colin Y, Cartron JP, Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995;10:224-8.
11. Race RR, Sanger R. Blood groups in man. 6th ed. Oxford: Blackwell, 1975.
12. Iwamoto S, Li J, Omi T, et al. Identification of a novel exon and spliced form of Duffy mRNA that is the predominant transcript in both erythroid and postcapillary venule endothelium. Blood 1996;87:378-85.
13. Miller LH, Mason SJ, Clyde DF, McGinniss MH. The resistance factor to Plasmodium vivax in blacks. The Duffy blood-group genotype, FyFy. N Engl J Med 1976;295:302-4.
14. Hadley TJ, Peiper SC. From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood 1997;89:3077-91.
15. Chaudhuri A, Zbrzezna V, Johnson C, et al. Purification and characterization of an erythrocyte membrane protein complex carrying Duffy blood group antigenicity. Possible receptor for Plasmodium vivax and Plasmodium knowlesi malaria parasite. J Biol Chem 1989;264:13770-4.
16. Horuk R, Colby TJ, Darbonne WC, et al. The human erythrocyte inflammatory peptide (chemokine) receptor. Biochemical characterization, solubilization, and development of a binding assay for the soluble receptor. Biochemistry 1993;32:5733-8.
17. Chaudhuri A, Zbrzezna V, Polyakova J, et al. Expression of the Duffy antigen in K562 cells. Evidence that it is the human erythrocyte chemokine receptor. J Biol Chem 1994;269:7835-8.
18. Horuk R, Chitnis CE, Darbonne WC, et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 1999;261:1182-4.
19. Darbonne WC, Rice GC, Mohler MA, et al. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991;88:1362-9.
20. Tournamille C, Le Van Kim C, Gane P, et al. Close association of the first and fourth extracellular domains of the Duffy antigen/receptor for chemokines by a disulfide bond is required for ligand binding. J Biol Chem 1997;272:16274-80.
21. Hadley TJ, Lu ZH, Wasniowska K, et al. Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. J Clin Invest 1994;94:985-91.
22. Peiper SC, Wang ZX, Neote K, et al. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995;181:1311-7.
23. Chaudhuri A, Nielsen S, Elkjaer ML, et al. Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. Blood 1997;89:701-12.
24. Horuk R, Martin A, Hesselgesser J, et al. The Duffy antigen receptor for chemokines: structural analysis and expression in the brain. J Leukoc Biol 1996;59:29-38.
25. Chown B, Lewis M, Kaita H. The Duffy blood group system in caucasians: evidence for a new allele. Am J Hum Genet 1965;17:384-9.
26. Murphy MT, Templeton LJ, Fleming J, et al. Comparison of Fy(b) status as determined serologically and genetically. Transfus Med 1997;7:135-41.
27. Parasol N, Reid M, Rios M, et al. A novel mutation in the coding sequence of the FY*B allele of the Duffy chemokine receptor gene is associated with an altered erythrocyte phenotype. Blood 1998;92:2237-43.
28. x (abstract). Transfusion 1998;38(Suppl):102S.
29. Tournamille C, Le Van Kim C, Gane P, et al. Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fy(x) individuals. Blood 1998;92:2147-56.
30. Olsson ML, Smythe JS, Hansson C, et al. The Fy(x) phenotype is associated with a missense mutation in the Fy(b) allele predicting Arg89Cys in the Duffy glycoprotein. Br J Haematol 1998;103:1184-91.
31. Nichols ME, Rubinstein P, Barnwell J, et al. A new human Duffy blood group specificity defined by a murine monoclonal antibody. Immunogenetics and association with susceptibility to Plasmodium vivax. J Exp Med 1987;166:776-85.
32. Sheay W, Nelson S, Martinez I, et al. Downstream insertion of the adenovirus tripartite leader sequence enhances expression in universal eukaryotic vectors. BioTechniques 1993;15:856-62.
33. Vallette F, Mege E, Reiss A, Adesnik M. Construction of mutant and chimeric genes using the polymerase chain reaction. Nucleic Acids Res 1989;17:723-33.
34. Liou HC, Sha WC, Scott ML, Baltimore D. Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation. Mol Cell Biol 1994;14:5349-59.
35. Yazdanbakhsh K, Lee S, Yu Q, Reid ME. Identification of a defect in the intracellular trafficking of a Kell blood group variant. Blood 1999;94:310-8.
36. Dodge JT, Mitchell C, Hanahan DJ. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 1963;100:119-30.
37. Robb RJ, Greene WC, Rusk CM. Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen. J Exp Med 1984;160:1126-46.
38. Von Heijne G. Membrane protein structure prediction. Hydrophobicity analysis and the positive-inside rule. J Mol Biol 1992;225:487-94.
39. Von Heijne G. Signals for protein targeting into and across membranes. Subcell Biochem 1994;22:1-19.
40. Hartmann E, Rapoport TA, Lodish HF. Predicting the orientation of eukaryotic membrane-spanning proteins. Proc Natl Acad Sci U S A 1989;86:5786-90.
41. Harley CA, Tipper DJ. The role of charged residues in determining transmembrane protein insertion orientation in yeast. J Biol Chem 1996;271:24625-33.
42. Mallinson G, Burgess G, Hook S, et al. A caucasian individual with the Fy(a-b-) phenotype has a novel defect in the FY gene (abstract). Transfus Med 1995;5(Suppl 1):19.
43. Reid ME. Molecular basis for blood groups and function of carrier proteins. In: Silberstein LE, ed. Molecular and functional aspects of blood group antigens. Bethesda: American Association of Blood Banks, 1995:75-125.
44. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-77.
45. Huang YX, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996;2:1240-3.
46. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-45.
47. Bradley D, Newbold CI, Warrell DA. Malaria. In: Weatherall DJ, Ledingham JGG, Warrell DA, eds. Oxford textbook of medicine. Oxford, UK: Oxford University Press, 1996:835-63.
48. Wiesenfeld SL. Selective advantage of the sickle-cell trait. Science 1968;160:437.